ASSESSMENT OF QUALITY OF LIFE IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AND ATRIAL FIBRILLATION
Keywords:
Abstract
We studied 124 patients with acute myocardial infarction (AMI) and atrial fibrillation (AF) who were treated in the intensive care unit of Samarkand regional branch of the Republican Specialised Scientific and Practical Medical Centre of Cardiology. To determine the quality of life of AMI and FP patients we developed a software product "Assessment of patients' quality of life and their compliance to treatment". The study revealed that out of 124 patients with AMI and FP 37 (29,8%) patients had unsatisfactory quality of life, 35 (28,2%) patients had satisfactory, 28 (22,5%) patients had good and 24 (19,35%) patients had excellent quality of life. The quality of life was much higher in patients without FP, i.e. 28 (33.3%) patients had excellent quality of life, 30 (35.7%) patients had good quality of life, 19 (22.6%) patients had satisfactory quality of life and 7 (8.3%) patients rated their condition as unsatisfactory. Thus, the results of our study showed that patients with AMI without FP had good QoL in contrast to patients with AMI+FP. This indicates that FP causes deterioration of QOL indicators in the form of increased severity of disease symptoms, restriction of physical activity, disorders in the psycho-emotional sphere. The condition of patients with AMI+FP is assessed as uncompliant, whereas patients with isolated AMI were less compliant. Occurrence of atrial fibrillation paroxysms may have been associated with the lack of compliance to the medications prescribed by the attending physician and reduced quality of life of patients.
Similar Articles
-
Caries: Diagnostics And Treatment
The American Journal of Medical Sciences and Pharmaceutical Research: No. 02 (2021) / Ahrorova Malika Shavkatovna, -
Hygienic Assessment Of The Impact Of Adverse Factors On The State Of Operating Greenhouse Farms
The American Journal of Medical Sciences and Pharmaceutical Research: No. 04 (2021) / Shavkat Mamirovich Turdiev, Dinara Makhkambaevna Khashirbaeva, -
EMBRACING HARMONY IN ONE HEALTH: NAVIGATING ZOONOTIC CHALLENGES AND HUMAN HEALTH SOLUTIONS WORLDWIDE
The American Journal of Medical Sciences and Pharmaceutical Research: No. 02 (2024) / Zahra Zahid Piracha, Umar Saeed, Nouman Tariq, Zahra Zahid Piracha, Syed Shayan Gilani, Maria Rauf, Hussian Ghyas, Nouman Ahmad Aulakh, Abrisham Akbariansaravi, Aiman Riaz, Ahmad Shareef, Muhammad Ishaque, Huzaifa Khatak, Hafsa Khurshid, -
Assessment Of Some Functional Indicators Of The Oral Cavity Working In Tobacco Production
The American Journal of Medical Sciences and Pharmaceutical Research: No. 10 (2020) / Nazarova Nodira Sharipovna , Sitora Baizakova , Sevinch Ismailova ,
References
Kadyrova F. et al. Поширенiсть бессимптомно гiперурикемii серед хворих з iшемiчною хворобою //Здобутки клінічної і експериментальної медицини. – 2017. – №. 2.
Насырова З. А., Абдуллоева М. Д., Усаров Ш. А. У. Стратификация факторов риска при ишемической болезни сердца //Journal of cardiorespiratory research. – 2021. – Т. 1. – №. 3. – С. 14-17.
Ташкенбаева Э. Н., Насырова З. А., Тоиров А. Э. Течение нестабильных вариантов стенокардии при полиморбидных состояниях //Colloquium-journal. – Голопристанський міськрайонний центр зайнятості Голопристанский районный центр занятости, 2019. – №. 27-3. – С. 45-49.
Элламонов С. Н. и др. Факторы прогрессирования артериальной гипертензии у больных в коморбидности с сахарным диабетом 2 типа //Journal of cardiorespiratory research. – 2021. – Т. 1. – №. 2. – С. 16-21.
Saito S, Teshima Y, Fukui A et al. Glucose fluctuations increase the incidence of atrial fibrillation in diabetic rats. Cardiovasc Res. 2014;104(1):5–14. https://doi.org/10.1093/cvr/cvu176
Schmitt J, Duray G, Gersh B et al. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J. 2009;30(9):1038–1045.
Schnabel RB, Yin X, Gona P et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet. 2015;386(9989):154–162. https://doi.org/10.1016/S0140-6736(14)61774-8
Shanmugasundaram M, Paul T, Hashemzadeh M et al. Outcomes of percutaneous coronary intervention in atrial fibrillation patients presenting with acute myocardial infarction: analysis of nationwide inpatient sample database. Cardiovasc Revasc Med. 2020;21(7):851–854.
Shiga T, Wajima Z, Inoue T, et al. Magnesium prophylaxis for arrhythmias after cardiac surgery: a meta-analysis of randomized controlled trials. Am J Med. 2004;117:325–333.
Simmers MB, Cole BK, Ogletree ML et al. Hemodynamics associated with atrial fibrillation directly alters thrombotic potential of endothelial cells. Thromb Res. 2016;143:34–39
Soliman EZ, Lopez F, O’Neal WT et al. Atrial fibrillation and risk of ST-segment–elevation versus non–ST-segment–elevation myocardial infarction: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2015;131(21):1843–1850.
Steinberg JS, Zelenkofske S, Wong SC, et al. Value of P-wave signal-averaged ECG for predicting atrial fibrillation after cardiac surgery. Circulation. 2017;88:2618–2622
Tanigawa M, Fukatani M, Konoe A, et al. Prolonged and fractionated right atrial electrograms during sinus rhythm in patients with paroxysmal atrial fibrilla-tion and sinus sick node syndrome. J Am Coll Cardiol. 2018;17:403–408.
Tereshchenko LG, Rizzi P, Mewton N et al. Infiltrated atrial fat characterizes underlying atrial fibrillation substrate in patients at risk as defined by the ARIC atrial fibrillation risk score. Int J Cardiol. 2014;172(1):196–201.
Toh N, Kanzaki H, Nakatani S et al. Left atrial volume combined with atrial pump function identifies hypertensive patients with a history of paroxysmal atrial fibrillation. Hypertension. 2020;55:1150– 1156.
van Diepen S, Siha H, Fu Y et al. Do baseline atrial electrocardiographic and infarction patterns predict new-onset atrial fibrillation after ST-elevation myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial. J Electrocardiol. 2021;43(4):351–358.
Vilani GQ, Piepoli M, Cripps T, et al. Atrial late potentials in patients with paroxysmal atrial fibrillation detected using a high gain, signal-averaged esophageal lead. PACE. 2016;17:1118–1123.
Villareal R, Hariharan R, Liu B, et al. Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol. 2004;43:742–748.
Violi F, Soliman EZ, Pignatelli P et al. Atrial fibrillation and myocardial infarction: a systematic review and appraisal of pathophysiologic mechanisms. J Am Heart Assoc. 2016;5(5):e003347.
Wang J, Yang YM, Zhu J. Mechanisms of new-onset atrial fibrillation complicating acute coronary syndrome. Herz. 2015;40(S1):18–26.
Wong CX, Sullivan T, Sun MT et al. Obesity and the risk of incident, post-operative, and post-ablation atrial fibrillation: a meta-analysis of 626,603 individuals in 51 studies. JACC Clin Electrophysiol. 2015;1(3):139–152.
Yamada T, Fukunami M, Shimonagata T, et al. Dispersion of signal-averaged P wave duration on precordial body surface in patients with paroxysmal atrial fibrillation. Eur Heart J.2018;20:211–220.
Zakynthinos E, Pappa N. Inflammatory biomarkers in coronary artery disease. J Cardiol. 2019;53(3):317– 333
